Literature DB >> 19684406

Mesh fixation with autologous platelet-rich fibrin sealant in inguinal hernia repair.

I H J T de Hingh1, S W Nienhuijs, E P Overdevest, K Scheele, P A M Everts.   

Abstract

BACKGROUND: Chronic pain is the main complication following inguinal hernia repair. A possible explanatory factor is the suture fixation of the mesh. Glue fixation might overcome this problem. Albeit at a very low frequency, human and bovine components of fibrin sealants currently available could contain blood-borne pathogens. Autologous platelet-rich fibrin sealant (P-RFS) eliminates this risk and has additional advantages such as hemostatic and antibacterial effects. Therefore, its feasibility was assessed in inguinal hernia repair, with a focus on pain.
METHODS: In 22 patients with primary inguinal hernia, the mesh was fixated with P-RFS. Data included operative variables, complications, pain scores and neurological examinations. Long-term follow-up was 22.2 months (SD 2.2) postoperatively.
RESULTS: After 2 weeks, visual analogue scale and disability pain scores were lower than they were preoperatively. Complications at 3 months were 1 recurrence, 1 chronic pain and 6 sensory disturbances. At the last clinical evaluation, the recurrence was planned for repair due to discomfort. No chronic pain, sensory disorders or discomfort was reported at long-term follow-up.
CONCLUSION: Mesh fixation with autologous P-RFS is feasible. If there is a preference for autologous material, P-RFS is indicated. If glue fixation becomes standard, further randomized studies are warranted for this alternative. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19684406     DOI: 10.1159/000233526

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  1 in total

1.  Platelet-Rich Fibrin as an Aid to Soft- and Hard-Tissue Healing.

Authors:  Rahul Sharma; Parveen Sharma; Sneha D Sharma; Naveen Chhabra; Ashish Gupta; Deepankar Shukla
Journal:  J Maxillofac Oral Surg       Date:  2019-12-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.